14Mar 2022
Cytokine Adsorption in Critically Ill COVID-19 Patients, a Case-Control Study

Cytokine Adsorption in Critically Ill COVID-19 Patients, a Case-Control Study

New coronavirus disease (COVID-19) has become an international emergency. Intensive care unit (ICU) patients with the disease also present multiple organ failure, so that that blood purification techniques might be a good choice in their treatment. The study aimed to investigate the role of cytokine removal in COVID-19 patients managed in ICUs. The study has demonstrated a decrease in CRP, fibrinogen and increase in lymphocyte count in the patients having cytokine adsorption. Still, there was no clinical reflection of these benefits and no reduction in mortality. Even though there is a physiopathologic rationale to use cytokine adsorption techniques for immunomodulation in critically ill COVID-19 patients, it is early to make strong suggestions about their benefits.

  • #critical care

Like

Save

Share